Want to see IN:XPROINDIA full AI Analyst Report?
Top Page
XPRO India Limited
(XPROINDIA)
Select Model
Select Model
Rating:44Neutral
Price Target:
₹1,227.00
▼(-11.52% Downside)
Action:Reiterated
Date:08/05/26
The score is primarily weighed down by weak financial performance—especially two years of strongly negative free cash flow and a sharp drop in FY2026 earnings—alongside rising debt. Technicals add further caution with the stock trading below its 20- and 50-day averages and only modest momentum. Valuation is also a headwind due to a very high P/E and a low dividend yield.
Positive Factors
Repeat-order business model
Supplying products that require consistent specifications and dependable continuity can support repeat purchasing and deeper customer relationships. This creates a more durable revenue base than purely transactional demand, while allowing manufacturing expertise and product consistency to reinforce customer retention over time.
Negative Factors
Profitability deterioration
The latest decline in revenue alongside a sharp reduction in net income signals weaker operating momentum and reduced earnings power. If this trajectory persists, it could constrain reinvestment, weaken returns on the company’s asset base, and make future growth more dependent on execution or external financing.
Read all positive and negative factors
Positive Factors
Negative Factors
Repeat-order business model
Supplying products that require consistent specifications and dependable continuity can support repeat purchasing and deeper customer relationships. This creates a more durable revenue base than purely transactional demand, while allowing manufacturing expertise and product consistency to reinforce customer retention over time.
Read all positive factors
XPRO India Limited (XPROINDIA) vs. iShares MSCI India ETF (INDA)
Market Cap
₹29.70B
Dividend Yield0.15%
Average Volume (3M)11.21K
Price to Earnings (P/E)92.1
Beta (1Y)1.34
Revenue Growth-1.23%
EPS Growth66.26%
CountryIN
Employees658
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)14.05
Shares Outstanding23,470,379
10 Day Avg. Volume11,277
30 Day Avg. Volume11,211
Financial Highlights & Ratios
PEG Ratio-2.36
Price to Book (P/B)3.03
Price to Sales (P/S)4.55
P/FCF Ratio-20.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XPRO India Limited Business Overview & Revenue Model
Company Description
Xpro India Limited processes and sells polymers primarily in India. The company offers dielectric films for applications comprising power transmission and distribution, motor run, power film/electronic, magnetic lighting ballast, microwave oven, l...
How the Company Makes Money
XPRO India Limited primarily makes money by manufacturing and selling polymer-based packaging and industrial material products to business customers. Its revenue model is centered on (1) product sales from its manufacturing operations, where earni...
XPRO India Limited Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
63
Positive
Cash Flow
34
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.35B | 5.05B | 5.35B | 4.65B | 5.11B | 4.72B |
| Gross Profit | 1.22B | 1.05B | 1.08B | 1.48B | 1.61B | 1.22B |
| EBITDA | 687.65M | 474.16M | 691.21M | 763.08M | 769.51M | 647.19M |
| Net Income | 326.60M | 192.34M | 379.97M | 438.79M | 453.64M | 449.32M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 12.18B | 9.93B | 6.77B | 3.40B | 3.35B |
| Cash, Cash Equivalents and Short-Term Investments | 2.98B | 2.99B | 2.61B | 2.05B | 264.11M | 193.63M |
| Total Debt | 0.00 | 3.25B | 2.69B | 390.00M | 386.82M | 898.87M |
| Total Liabilities | -7.98B | 4.20B | 3.82B | 1.17B | 1.07B | 1.63B |
| Stockholders Equity | 7.98B | 7.60B | 6.10B | 5.61B | 2.34B | 1.72B |
Cash Flow | ||||||
| Free Cash Flow | -660.36M | -1.14B | -2.62B | 58.15M | 465.36M | 420.77M |
| Operating Cash Flow | -20.19M | 270.46M | 252.35M | 439.79M | 828.55M | 486.21M |
| Investing Cash Flow | -1.41B | -1.75B | -1.31B | -3.20B | -582.75M | -104.59M |
| Financing Cash Flow | 806.86M | 1.58B | 2.08B | 2.78B | -431.40M | -211.58M |
XPRO India Limited Technical Analysis
Positive
1386.80
Price Trends
1275.81
Negative
1223.42
Positive
1095.17
Positive
Market Momentum
25.62
Negative
52.88
Neutral
69.24
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:XPROINDIA, the sentiment is Positive. The current price of 1386.8 is above the 20-day moving average (MA) of 1198.25, above the 50-day MA of 1275.81, and above the 200-day MA of 1095.17, indicating a neutral trend. The MACD of 25.62 indicates Negative momentum. The RSI at 52.88 is Neutral, neither overbought nor oversold. The STOCH value of 69.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:XPROINDIA.
XPRO India Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹68.51B | 48.10 | ― | 0.23% | 91.44% | 19.67% | |
65 Neutral | ₹32.67B | 47.89 | ― | 0.79% | 0.96% | -28.98% | |
60 Neutral | ₹38.95B | 73.22 | ― | 0.12% | 41.09% | 618.16% | |
57 Neutral | ₹24.97B | 16.39 | ― | 0.11% | 19.47% | 11.49% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | ₹65.35B | 179.09 | ― | 0.04% | 18.00% | 3.85% | |
44 Neutral | ₹29.70B | 92.15 | ― | 0.15% | -1.23% | 66.26% |
* General Sector Average
IN:XPROINDIA
XPRO India Limited
1,294.90
62.64
5.08%
IN:FCL
Fineotex Chemical Limited
57.76
34.16
144.76%
IN:NEOGEN
Neogen Chemicals Ltd.
2,366.40
803.40
51.40%
IN:NOCIL
NOCIL Limited
189.35
7.94
4.38%
IN:ROSSARI
Rossari Biotech Ltd
447.40
-179.19
-28.60%
IN:TATVA
Tatva Chintan Pharma Chem Limited
1,605.65
588.92
57.92%
XPRO India Limited Corporate Events
XPRO India Outlines TDS Rules on Recommended FY26 Dividend
Jun 17, 2026
XPRO India Limited has notified exchanges and shareholders that its board has recommended a dividend of 20% per equity share of INR 10, equivalent to INR 2 per share for the financial year ended March 31, 2026. The company has issued detailed guid...
XPRO India Says No Undisclosed Developments Behind Share Volume Surge
Jun 16, 2026
XPRO India Limited said it has been regularly disclosing all material and price-sensitive information in compliance with SEBI’s Listing Regulations, after the stock exchanges flagged a significant spike in trading volumes. The company added ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.